It is our mission to bridge discovery and valorization with antibodies. It is the objective of PharmAbs to support academic groups and biotech companies active in blue, green and red biotechnology in creating value for their project by generating tailor-made antibodies, by demonstrating in vivo proof-of-principle and initiate development towards the market. PharmAbs is a technology-based research center applying a product-focused and market-oriented strategy. 

Collaborative R&D programs will be based on clinically relevant and fully validated targets identified by academic groups or biotech companies.  Once sufficiently consolidated, these programs will be valorized, either through traditional licensing agreements with pharmaceutical and biotech companies, or through the creation of spin-off companies.

The strategic focus of the platform is to support projects aiming at innovative monoclonal therapeutics, antibody-based diagnostics, imaging tools and immunosensors.